Literature DB >> 12649634

Early expression of a pathophysiological feature of schizophrenia: saccadic intrusions into smooth-pursuit eye movements in school-age children vulnerable to schizophrenia.

Randal G Ross1.   

Abstract

OBJECTIVE: Neurodevelopmental hypotheses of schizophrenia propose that the responsible pathology occurs much earlier than the usual onset of illness in late adolescence. Nonspecific neurocognitive and behavioral deficits found in children vulnerable to schizophrenia support this hypothesis. This report describes early deficits in a putative genetic endophenotype, saccadic intrusions into smooth-pursuit eye movements (SPEM).
METHOD: SPEM were recorded in 189 children aged 6-15 years: 49 children with schizophrenia, 60 nonpsychotic first-degree relatives, and 80 typically developing children.
RESULTS: Children with schizophrenia demonstrated poorer gain and a significantly increased frequency of leading saccades and large anticipatory saccades; however, only leading saccades differentiated first-degree relatives from typical children. Admixture analysis indicates that 94% of children with schizophrenia, 50% of first-degree relatives, and 19% of typically developing children have abnormally increased frequencies of leading saccades.
CONCLUSIONS: Typically developing young school-age children have a leading saccade phenotype similar to that of adults, suggesting this brain function is fully developed by early school-age years. The abnormal leading saccade phenotype, a schizophrenia-associated familial brain dysfunction, is present by 6 years of age, more than a decade before the highest risk for onset of psychosis. Treatment and prevention strategies will need to consider the early neurodevelopmental nature of schizophrenia.

Entities:  

Mesh:

Year:  2003        PMID: 12649634     DOI: 10.1097/01.CHI.0000046818.95464.42

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  15 in total

Review 1.  Approaches for adolescents with an affected family member with schizophrenia.

Authors:  Vaibhav A Diwadkar; Konasale M Prasad; Matcheri S Keshavan
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 5.285

2.  Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study.

Authors:  Matcheri S Keshavan; Vaibhav A Diwadkar; Debra M Montrose; Jeff A Stanley; Jay W Pettegrew
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

Review 3.  A brief taxometrics primer.

Authors:  Theodore P Beauchaine
Journal:  J Clin Child Adolesc Psychol       Date:  2007 Oct-Dec

4.  Saccades during symmetrical vergence.

Authors:  Olivier A Coubard; Zoï Kapoula
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-11-22       Impact factor: 3.117

Review 5.  Ten good reasons to consider biological processes in prevention and intervention research.

Authors:  Theodore P Beauchaine; Emily Neuhaus; Sharon L Brenner; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2008

6.  The stability of inhibitory and working memory deficits in children and adolescents who are children of parents with schizophrenia.

Authors:  Randal G Ross; Brandie Wagner; Shari Heinlein; Gary O Zerbe
Journal:  Schizophr Bull       Date:  2007-09-14       Impact factor: 9.306

7.  SPEM dysfunction and general schizotypy as measured by the SSQ: a controlled study.

Authors:  Dirk van Kampen; Jan Berend Deijen
Journal:  BMC Neurol       Date:  2009-06-29       Impact factor: 2.474

Review 8.  Neurophysiological biomarkers for drug development in schizophrenia.

Authors:  Daniel C Javitt; Kevin M Spencer; Gunvant K Thaker; Georg Winterer; Mihály Hajós
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

9.  Use of the ADOS and ADI-R in children with psychosis: importance of clinical judgment.

Authors:  Judith A Reaven; Susan L Hepburn; Randal G Ross
Journal:  Clin Child Psychol Psychiatry       Date:  2008-01       Impact factor: 2.544

Review 10.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.